However, the effect was augmented with dual T-cell immunoreceptor with Ig (immunoglobulin), T-cell immunoreceptor with Ig and ITIM domains (TIGIT), and PD-1 checkpoint blockade, resulting in increased functional CD4+ and CD8+ T-cell infiltration and improved tumor control. The gene discussed is CD8A; the disease is neoplasm.